This educational activity is designed for surgical dermatologists, Mohs surgeons, dermatologists, and other healthcare professionals who manage patients with advanced or metastatic basal cell carcinoma or cutaneous squamous cell carcinoma. Our goal is to help these clinicians better explain the risk assessment of patients with non-melanoma skin cancers (NMSCs) who may derive optimal benefit with new systemic therapies when compared to Mohs surgery, incorporate patient trials data for systemic immunotherapy into the treatment of both advanced cutaneous squamous cell carcinoma and basal cell carcinoma, and collaborate with other members of the NMSC healthcare team to provide a multidisciplinary approach to the development of treatment plans for individuals with high-risk NMSCs.

RELEASED DATE: June 10, 2025
EXPIRATION DATE: June 10, 2026

This enduring activity is designed for healthcare professionals involved in the management of patients with non-melanoma skin cancers (NMSCs). This case-based presentation—led by expert faculty and enriched with Patient Spotlight Videos—address complex and evolving NMSC cases to enhance clinical decision-making and patient outcomes. Participants will gain practical insights into modern treatment selection, the expanding role of immune checkpoint inhibitors, and effective multidisciplinary and patient-centered care strategies. Supporting resources, including an engaging Whiteboard Animation, will reinforce key concepts, promoting sustained improvement in care delivery across academic and community dermatology practices nationwide.

RELEASED DATE: January 23, 2026
EXPIRATION DATE: January 23, 2027

With multiple immunotherapy treatment options and combinations available for the management of melanoma, clinicians require up-to-date guidance on the application of clinical data—including recent findings presented at ASCO—to support shared decision-making and multidisciplinary care. In this concise program, Dr. Emily Ruiz reviews current evidence-based guidelines, presents clinical data informing treatment decisions, and demonstrates best practices for applying this data to patients with melanoma.

RELEASED DATE: July 31, 2025
EXPIRATION DATE: July 31, 2026

This program will dive into the latest advances in the management of non-melanoma skin cancers (NMSCs), including new data presented at ESMO. Through real-world clinical cases, faculty will guide participants in applying emerging evidence—particularly regarding neoadjuvant and adjuvant immune checkpoint inhibitors—to personalize treatment based on patient- and disease-specific risk factors. The session will also emphasize shared decision-making and multidisciplinary care to support coordinated, patient-centered treatment planning for individuals with advanced NMSCs.

RELEASED DATE: November 21, 2025
EXPIRATION DATE: November 21, 2026